AI assistant
Sending…
CORCEPT THERAPEUTICS INC — Director's Dealing 2021
May 28, 2021
30681_dirs_2021-05-28_0fb3e190-78ae-4419-b041-b2319ab5a884.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-05-26
Reporting Person: Alton Gregg H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-26 | Stock Option (Right to Buy) | $21.45 | A | 20000 | Acquired | 2031-05-25 | Common Stock (20000) | Direct |
Footnotes
F1: Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over a one-year period.
More from CORCEPT THERAPEUTICS INC
Regulatory Filings
2026
Jun 17
Legal Proceedings Report
2026
Jun 3
Share Issue/Capital Change
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Call Transcript
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25